Epigene Labs is creating an intelligence-augmenting solution for precision oncology research and drug development. Designed by cancer scientists for cancer scientists, the company’s mCube platform accelerates data-driven drug discovery, biomarker identification, and patient selection — to bring better treatments to patients faster. Based in Paris and Boston, Epigene Labs was initially incubated at the Harvard Innovation Labs and launched in France with the support of prominent European investors. Epigene Labs has partnerships with world-class cancer research institutes and biopharmaceutical companies.